Trilinolein cream to prevent eczema relapse in remission
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests a new cream called trilinolein cream to see if it can prevent eczema flare-ups in people whose moderate-to-severe atopic dermatitis is currently calm. It's a way to help keep your skin clear longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with atopic dermatitis (eczema).
- Your eczema was moderate to severe in the past, but is now in remission (mostly clear skin).
- You are at least 2 years old and no older than 75.
- You are not currently using strong eczema treatments like Dupixent, JAK inhibitors, or oral steroids.
- You do not have another skin condition in the area to be treated, and you are not allergic to the cream's ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an ointment called QLM3003 is safe and helps adults with mild to moderate atopic dermatitis (eczema). It may be a new treatment option for people whose eczema affects small areas of skin.
This study tests an investigational shot (tralokinumab) plus a steroid cream for children with moderate-to-severe eczema that hasn't been controlled by creams alone. It aims to see if the combination is safe and works better than the cream alone.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
This trial tests a new medication for people with moderate-to-severe eczema. It aims to see if the treatment is safe and effective for reducing symptoms.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
This trial tests a new drug called IBI3002 in people with moderate-to-severe atopic dermatitis (eczema) to see if it is safe and tolerable. It may help reduce skin inflammation and itching.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.